Christopher Capelli
Fondateur chez SOLITON, INC.
Postes actifs de Christopher Capelli
| Sociétés | Poste | Début | Fin |
|---|---|---|---|
| SOLITON, INC. | Directeur/Membre du Conseil | 01/02/2021 | - |
| Fondateur | 01/02/2021 | - | |
| Corporate Officer/Principal | 01/02/2021 | - | |
| AUTONOMIX MEDICAL, INC. | Directeur/Membre du Conseil | 01/09/2023 | - |
| Independent Dir/Board Member | 01/09/2023 | - |
Historique de carrière de Christopher Capelli
Anciens postes connus de Christopher Capelli
| Sociétés | Poste | Début | Fin |
|---|---|---|---|
| The University of Texas at Austin | Corporate Officer/Principal | 01/03/2005 | 01/08/2014 |
| University of Pittsburgh | Corporate Officer/Principal | 01/03/2001 | 01/02/2005 |
| Biointerface Technologies, Inc. | Fondateur | 01/01/1987 | 01/01/1998 |
| President | 01/01/1987 | 01/01/1998 |
Formation de Christopher Capelli
| Massachusetts Institute of Technology | Undergraduate Degree |
| University of Wisconsin School of Medicine & Public Health | Doctorate Degree |
Statistiques
Internationale
| Etats-Unis | 8 |
Opérationnelle
| Corporate Officer/Principal | 3 |
| Director/Board Member | 2 |
| Founder | 2 |
Sectorielle
| Consumer Services | 4 |
| Health Technology | 3 |
| Finance | 2 |
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Sociétés liées
| Sociétés cotées | 1 |
|---|---|
| AUTONOMIX MEDICAL, INC. | Health Technology |
| Entreprise privées | 2 |
|---|---|
Soliton, Inc. (Texas)
 Soliton, Inc. (Texas) Medical SpecialtiesHealth Technology Soliton, Inc. is a medical development company, which engages in the development of healthcare technological devices for medical and cosmetic treatments. Its technology platform include Rapid Acoustic Pulse, a device uses rapid pulses of designed acoustic shockwaves to disrupt cellular structures in the dermal and subdermal tissue. The firm is also in the pre-revenue stage with its first products being developed for the removal of tattoos and the reduction of cellulite. The company was founded by Walter V. Klemp and Christopher Capelli on March 27, 2012 and is headquartered in Houston, TX. | Health Technology |
| Biointerface Technologies, Inc. |
- Bourse
- Insiders
- Christopher Capelli
- Expérience
